Clinical Trial Update: A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIV [Phase 2]

View source ↗

Summary

Phase 2 trial comparing adefovir vs. tenofovir for lamivudine-resistant hepatitis B virus in people with HIV; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Hepatitis B

Drugs mentioned

• Adefovir (adefovir)
• Tenofovir (Tenofovir)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Hepatitis B | Phase 2 | Status: COMPLETED